HT
HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $221.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 39.18%
Rev. growth 30.79%
FCF growth N/A
Profitability
10 /100
Weak Net margin 339.20%
Op. margin 327.19%
FCF margin 289.51%
Quality
6 /100
Poor ROA 121.47%
Asset turnover 0.36x
ROIC 151.08%
Debt
59 /100
Moderate Current ratio 1.89x
Int. coverage -24.19x
Net debt/EBITDA 0.19x
Stability
40 /100
Moderate Rev. volatility 29.88%
EPS volatility 14.49%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o HTGMQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John L. Lubniewski
Employees
53
Headquarters
Tucson
Nadchodzące wydarzenia
13 LIS
Earnings
Upcoming earnings report